The flavonoid Astragalin shows anti‐tumor activity and inhibits PI3K/AKT signaling in gastric cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The flavonoid Astragalin shows anti‐tumor activity and inhibits PI3K/AKT signaling in gastric cancer
Authors
Keywords
-
Journal
Chemical Biology & Drug Design
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-08-16
DOI
10.1111/cbdd.13933
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions
- (2021) Ayda Baghery Saghchy Khorasani et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Astragalus polysaccharides alleviates LPS‐induced inflammation via the NF‐κB/MAPK signaling pathway
- (2020) Na Dong et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A Review of the Pharmacological Action of Astragalus Polysaccharide
- (2020) Yijun Zheng et al. Frontiers in Pharmacology
- PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond
- (2020) Sadegh Fattahi et al. LIFE SCIENCES
- Effect of Astragalus Polysaccharide on the Expression of VEGF and EGFR in Mice with Lewis Transplantable Lung Cancer
- (2019) Lichun Zhao et al. JCPSP-Journal of the College of Physicians and Surgeons Pakistan
- Targeting autophagy using natural compounds for cancer prevention and therapy
- (2019) Shuo Deng et al. CANCER
- Anti-tumor potential of astragalus polysaccharides on breast cancer cell line mediated by macrophage activation
- (2019) Wenfang Li et al. Materials Science & Engineering C-Materials for Biological Applications
- Burden of Gastric Cancer
- (2019) Aaron P. Thrift et al. Clinical Gastroenterology and Hepatology
- PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
- (2019) Ali S. Alzahrani SEMINARS IN CANCER BIOLOGY
- Natural compounds as potential adjuvants to cancer therapy: preclinical evidence
- (2019) Shian‐Ren Lin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway
- (2019) Jong Hyun Lee et al. PHARMACOLOGICAL RESEARCH
- Gastric cancer: epidemiology, prevention, classification, and treatment
- (2018) Robert Sitarz et al. Cancer Management and Research
- Apoptotic Effect of Astragalin in Melanoma Skin Cancers via Activation of Caspases and Inhibition of Sry-related HMg-Box Gene 10
- (2017) Ok Heui You et al. PHYTOTHERAPY RESEARCH
- Astragalin-induced cell death is caspase-dependent and enhances the susceptibility of lung cancer cells to tumor necrosis factor by inhibiting the NF-кB pathway
- (2017) Minghui Chen et al. Oncotarget
- p-Akt as a potential poor prognostic factor for gastric cancer: a systematic review and meta-analysis
- (2017) Fang Cao et al. Oncotarget
- The Regulation of NRF2 by Nutrient-Responsive Signaling and Its Role in Anabolic Cancer Metabolism
- (2017) Sae Bom Lee et al. ANTIOXIDANTS & REDOX SIGNALING
- The PI3K/AKT Pathway as a Target for Cancer Treatment
- (2016) Ingrid A. Mayer et al. Annual Review of Medicine
- Astragalus polysaccharide induces the apoptosis of human hepatocellular carcinoma cells by decreasing the expression of Notch1
- (2016) Wen-Hai Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Gastric cancer
- (2016) Eric Van Cutsem et al. LANCET
- Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer
- (2016) Evan C. Lien et al. NATURE CELL BIOLOGY
- Trisubstituted-Imidazoles Induce Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/mTOR Signaling Pathway
- (2016) Chakrabhavi Dhananjaya Mohan et al. PLoS One
- The PTEN/NRF2 Axis Promotes Human Carcinogenesis
- (2014) Ana I. Rojo et al. ANTIOXIDANTS & REDOX SIGNALING
- Inhibitory effects of astragalin on lipopolysaccharide-induced inflammatory response in mouse mammary epithelial cells
- (2014) Fengyang Li et al. JOURNAL OF SURGICAL RESEARCH
- Treatment of gastric cancer
- (2014) Michele Orditura WORLD JOURNAL OF GASTROENTEROLOGY
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- Growth hormone modulation of EGF-induced PI3K-Akt pathway in mice liver
- (2011) Ma. Eugenia Díaz et al. CELLULAR SIGNALLING
- Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors
- (2011) Johanna C. Bendell et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started